What's new?

Important news for our families!

Eli Lilly and Company has decided to discontinue our Glucagon Emergency Kit (Glucagon for injection, rDNA origin) from all markets. In Canada, we anticipate that the final date for the discontinuation to be the end of June 2023. We have decided to stop manufacturing GLUCAGON (Glucagon for injection, rDNA origin) and our GLUCAGON Emergency Kit globally due to decreased demand and to streamline our manufacturing processes.

Lilly is working to notify physicians, healthcare providers, hospitals, pharmacies, and wholesalers of the discontinuation timeline, to allow sufficient time to evaluate alternative glucagon options and to transfer these patients to alternate forms of treatment.

We currently anticipate the last distribution of GLUCAGON (Glucagon for injection, rDNA origin) from Lilly to pharmacy distributors in Canada will occur in approximately June 2023. Although this is the anticipated last date of distribution, GLUCAGON may be used until the expiry date on the product.

View our other articles